Conestoga Small Cap Fund Investors Class (CCASX)

37.99
Net Asset Value
+0.34%
1 Day
+6.30%
Year-to-Date
Overall Morningstar Rating
Small growth
Style or Category
No Load
Sales Expenses
1.50%
Expense Ratio
Below Average
Morningstar Risk Rating™
Investment Objective The investment seeks long-term growth of capital. Under normal market circumstances, the fund invests at least 80% of its net assets in equity securities of small-cap companies. Equity securities include American depositary receipts ("ADRs"), convertible securities, foreign and domestic common and preferred stocks, rights and warrants.

Performance

1 month+2.29% 3 years+7.59%
3 months+8.79% 5 years+13.29%
1 year+12.59% Since inception+10.94%
Data through --

Peer Comparisonvs. Small growth

 CCASXCategory
Performance 5-yr return+13.29%+7.26%
Expense ratio1.50%1.33%
Risk 5 year sharpe ratio0.700.61
Net assets$791.6M$849.2M
Average market cap$1.5B$3.0B
Average P/E33.126.1
Portfolio turnover12%12%

There are thousands of mutual funds to choose from. Get Money Magazine’s picks in all major categories.

Fund Management and Purchase Info

Fund familyConestoga Capital Advisors
Fund manager & tenureRobert Mitchell / 13 Years
Minimal initial investment$2,500.00
Minimum IRA investment--

Holdings

U.S. stock93.54%
Cash6.46%
International stock0.00%
Fixed income0.00%
Other0.00%
Top 5 Sectors
Portfolio weighting
Business service 19.67%
Healthcare 12.89%
Hardware 12.07%
Industrial materials 10.80%
Energy 8.99%
Top 10 Holdings
Portfolio weighting
OMCL Omnicell Inc3.63%
MLAB Mesa Laboratories Inc3.18%
VASC Vascular Solutions Inc3.14%
SPSC SPS Commerce Inc3.14%
NEOG Neogen Corp3.12%
BLKB Blackbaud Inc3.12%
CMN Cantel Medical Corp2.98%
TYL Tyler Technologies Inc2.85%
DORM Dorman Products Inc2.76%
AAON AAON Inc2.73%

Partner Offers

NextAdvisor